Richard Rosenquist Brandell has been honored as the Pharmaceutical Profile of the Year 2025 for his significant contributions to establishing a national infrastructure for...
A recent doctoral thesis from the Karolinska Institutet reveals significant insights into the long-term effects of chronic hypoparathyroidism, a rare endocrine disorder characterized by...